--- title: "[Steady Progress] The food delivery war is on pause, earnings season begins, opportunities for Hong Kong stocks in August are here" type: "Topics" locale: "zh-HK" url: "https://longbridge.com/zh-HK/topics/32685255.md" description: "#Hong Kong Stocks #Hang Seng Index #Pharmaceutical Stocks #New Energy Vehicles #Semiconductor Stocks #Market Trends #Investment Strategies## Hang Seng Index Trend and Bull-Bear Certificate Analysis - **Market Trends and Capital Flows** The Hang Seng Index has recently fluctuated around the 25,000-point mark, indicating a market consolidation trend. Niki suggests investors pay attention to the bull-bear certificate fund distribution chart to understand the proportion of bullish (bull certificates) and bearish (bear certificates) funds in the market. - The website (www.bocifp.com) updates the bull-bear certificate distribution chart daily, and investors are advised to develop a habit of checking it every day..." datetime: "2025-08-07T01:26:46.000Z" locales: - [en](https://longbridge.com/en/topics/32685255.md) - [zh-CN](https://longbridge.com/zh-CN/topics/32685255.md) - [zh-HK](https://longbridge.com/zh-HK/topics/32685255.md) author: "[说财经](https://longbridge.com/zh-HK/profiles/8322226.md)" --- > 支持的語言: [English](https://longbridge.com/en/topics/32685255.md) | [简体中文](https://longbridge.com/zh-CN/topics/32685255.md) # [Steady Progress] The food delivery war is on pause, earnings season begins, opportunities for Hong Kong stocks in August are here #Hong Kong Stocks #Hang Seng Index #Pharmaceutical Stocks #New Energy Vehicles #Semiconductor Stocks #Market Trends #Investment Strategies \## Hang Seng Index Trends and Bull-Bear Warrant Analysis \- \*\*Market Trends and Capital Flows\*\* The Hang Seng Index has recently fluctuated around the 25,000-point mark, indicating a consolidation phase. Niki advises investors to pay attention to the bull-bear warrant distribution chart to understand the market's bullish (bull warrants) and bearish (bear warrants) sentiment. \- The website (www.bocifp.com) updates the bull-bear warrant distribution chart daily, and investors are advised to make it a habit to check it regularly. \- The bull warrant ratio recently reached as high as 73%, indicating strong bullish sentiment, but after adjusting to 24,600 points, the ratio dropped to 65%, showing a return to market balance. \- When capital is overly concentrated (e.g., 70% bullish), the market may experience a reversal (killing bulls or bears), so investors should be cautious. \- Bull Warrant 57737, with a knock-out level of 24,200 points and leverage of about 31x, is suitable for investors bullish on the Hang Seng Index who believe it can hold above 25,000 points. \- Bear Warrant 62927, with a knock-out level of 25,288 points and leverage of about 47x, is suitable for bearish investors but carries high leverage risks. \- Investors are advised to allocate capital cautiously, avoid over-concentration in high-leverage products, and consider call/put warrants to mitigate risks. \## Pharmaceutical Sector: The Star Performer of the Year \- \*\*Strong Performance of Pharmaceutical Stocks\*\* In the first half of 2025, China's innovative drug exports have already matched last year's total, showing robust growth. Pharmaceutical stocks have generally outperformed the broader Hong Kong market, becoming a focal sector. \- The pharmaceutical R&D cycle is long (3-5 years), and 2025 is a breakthrough year for results, making it a key focus for investors. \- Recommended stocks: CSPC Pharmaceutical Group (1093)), related call warrant (18524), strike price HKD 13.4, leverage ~4x, expiring February 2026. \- Other hot pharmaceutical stocks: WuXi AppTec (2359), Akeso (9926), recently hitting all-time highs or consolidating at high levels, indicating healthy sector trends. \- Market positives: changes in centralized procurement policies, increased overseas licensing deals (e.g., upfront payments + profit-sharing models), and AI-driven R&D for CXO companies. \## New Energy Vehicle Sector: Opportunities and Challenges \- \*\*Market Competition and Stock Performance\*\* The new energy vehicle sector is highly competitive, with a rich variety of models domestically but facing trade barriers in exports. \- BYD (1211) has fallen to a three-month low (HKD 110), but capital inflows into bullish positions suggest investors see support potential at these levels. \- Reference call warrant: 18228, strike price HKD 131, leverage 3-4x, expiring July 2026. \- Put warrant (bearish): 15172, strike price HKD 109, leverage ~6x, expiring October 2025. \- Li Auto (2015) is relatively weak; reference call warrant (17074), strike price HKD 148, leverage ~5x, expiring December 2025. \- Xiaomi (1810), with its diversified business (smartphones, home appliances, etc.), has strong resilience, with its stock consolidating at high levels. Reference call warrant (16937), strike price HKD 62, leverage 5-6x, expiring February 2026. \- \*\*New Energy Vehicle Trends\*\* Domestic autonomous driving technology (e.g., RoboTaxi) is developing rapidly, attracting market attention, but intensified competition and price wars are affecting leading stocks. Investors should focus on companies with technological leadership and brand advantages. \## Semiconductor Sector: Pre-Earnings Expectations \- \*\*SMIC and Hua Hong Semiconductor\*\* SMIC (981) and Hua Hong Semiconductor (1347) are set to announce earnings on August 7, with high market anticipation. \- SMIC's stock remains at elevated levels, benefiting from regulatory scrutiny on NVIDIA and chip export restrictions. \- Recommended call warrant: 16557, strike price HKD 58, leverage ~4x, expiring March 2026. \- Hua Hong Semiconductor call warrant: 16630, strike price HKD 42, leverage ~3x. \- As a key national development sector, semiconductors have strong long-term prospects. Investors are advised to deploy capital based on earnings fundamentals. \## Platform Stocks: Investment Opportunities Amid Fierce Competition \- \*\*Market Competition and Cash-Burning Models\*\* Platform stocks like Meituan (3690) face intense competition in Hong Kong, offering premium services (e.g., umbrella delivery on rainy days, free deliveries for seniors) but suffering from cash-burning models that pressure stock prices. \- Investors are advised to wait for earnings announcements to confirm fundamental improvements before considering investments. \- Hong Kong, as a high-consumption market, attracts platform stocks, but short-term caution is warranted despite long-term expansion potential. \## Investment Strategies and Summary 1\. \*\*Identify Turning Points\*\*: Consider bottom-fishing when stocks (e.g., BYD) fall to unreasonably low levels. 2\. \*\*Follow the Trend\*\*: Capture short-term gains by buying into upward trends. 3\. \*\*Monitor Capital Flows and Fundamentals\*\*: Combine bull-bear warrant distributions, capital flows, and earnings data to gauge market sentiment and stock potential. \- The Hang Seng Index has been recovering since hitting bottom last September, and investors should seize sector rotation opportunities. \- \*\*Next Episode Preview\*\* Next Tuesday (August 12), we will review market performance, focusing on the latest developments in pharmaceuticals, new energy vehicles, and semiconductors, and answer viewer questions. $BYD COMPANY(01211.HK) $CSPC PHARMA(01093.HK) $SMIC(00981.HK) ### 相關股票 - [Hang Seng Index (00HSI.HK)](https://longbridge.com/zh-HK/quote/00HSI.HK.md) - [FI2 CSOP HSI (07500.HK)](https://longbridge.com/zh-HK/quote/07500.HK.md) - [ISHARESHSI (03115.HK)](https://longbridge.com/zh-HK/quote/03115.HK.md) - [FL2 CSOP HSI (07200.HK)](https://longbridge.com/zh-HK/quote/07200.HK.md) - [BYD COMPANY (01211.HK)](https://longbridge.com/zh-HK/quote/01211.HK.md) - [BYD COMPANY-R (81211.HK)](https://longbridge.com/zh-HK/quote/81211.HK.md) - [BYD HK SDR 10to1 (HYDD.SG)](https://longbridge.com/zh-HK/quote/HYDD.SG.md) - [BYD (002594.CN)](https://longbridge.com/zh-HK/quote/002594.CN.md) - [BYD Company Limited (BYDDF.US)](https://longbridge.com/zh-HK/quote/BYDDF.US.md) - [BYD Company (BYDDY.US)](https://longbridge.com/zh-HK/quote/BYDDY.US.md) - [CSPC PHARMA (01093.HK)](https://longbridge.com/zh-HK/quote/01093.HK.md) - [SMIC (00981.HK)](https://longbridge.com/zh-HK/quote/00981.HK.md) - [SMIC HK SDR 5to1 (HSMD.SG)](https://longbridge.com/zh-HK/quote/HSMD.SG.md) - [SMIC (688981.CN)](https://longbridge.com/zh-HK/quote/688981.CN.md) ## 評論 (1) - **大道无变 · 2025-08-07T10:34:59.000Z**: Continue